SEMLER SCIENTIFIC INC (SMLR)
US81684M1045 - Common Stock
We assign a fundamental rating of 8 out of 10 to SMLR. SMLR was compared to 193 industry peers in the Health Care Equipment & Supplies industry. SMLR gets an excellent profitability rating and is at the same time showing great financial health properties. SMLR may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, SMLR could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
SMLR had positive earnings in the past year.
SMLR had a positive operating cash flow in the past year.
SMLR had positive earnings in each of the past 5 years.
SMLR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SMLR has a better Return On Assets (26.36%) than 100.00% of its industry peers.
SMLR has a Return On Equity of 28.67%. This is amongst the best in the industry. SMLR outperforms 98.44% of its industry peers.
SMLR has a Return On Invested Capital of 25.77%. This is amongst the best in the industry. SMLR outperforms 98.96% of its industry peers.
SMLR had an Average Return On Invested Capital over the past 3 years of 28.91%. This is significantly above the industry average of 8.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.36% | ||
| ROE | 28.67% | ||
| ROIC | 25.77% |
ROA(3y)27.74%
ROA(5y)41.22%
ROE(3y)30.74%
ROE(5y)50.92%
ROIC(3y)28.91%
ROIC(5y)39.78%
1.3 Margins
SMLR has a better Profit Margin (30.18%) than 98.44% of its industry peers.
SMLR's Profit Margin has improved in the last couple of years.
SMLR has a better Operating Margin (32.64%) than 98.44% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
With an excellent Gross Margin value of 89.76%, SMLR belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.64% | ||
| PM (TTM) | 30.18% | ||
| GM | 89.76% |
OM growth 3Y-7.58%
OM growth 5Y5.61%
PM growth 3Y-5.96%
PM growth 5Y5.3%
GM growth 3Y-0.57%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SMLR is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
Compared to 5 years ago, SMLR has more shares outstanding
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SMLR has an Altman-Z score of 21.97. This indicates that SMLR is financially healthy and has little risk of bankruptcy at the moment.
SMLR has a Altman-Z score of 21.97. This is amongst the best in the industry. SMLR outperforms 94.27% of its industry peers.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 21.97 |
ROIC/WACC2.65
WACC9.72%
2.3 Liquidity
A Current Ratio of 10.64 indicates that SMLR has no problem at all paying its short term obligations.
The Current ratio of SMLR (10.64) is better than 92.71% of its industry peers.
SMLR has a Quick Ratio of 10.56. This indicates that SMLR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.56, SMLR belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.64 | ||
| Quick Ratio | 10.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 53.63% over the past year.
The Earnings Per Share has been growing by 31.87% on average over the past years. This is a very strong growth
SMLR shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.28%.
Measured over the past years, SMLR shows a very strong growth in Revenue. The Revenue has been growing by 25.98% on average per year.
EPS 1Y (TTM)53.63%
EPS 3Y16.48%
EPS 5Y31.87%
EPS growth Q2Q43.9%
Revenue 1Y (TTM)20.28%
Revenue growth 3Y20.88%
Revenue growth 5Y25.98%
Revenue growth Q2Q9.11%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.82, the valuation of SMLR can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 96.88% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.73, SMLR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.79, the valuation of SMLR can be described as very cheap.
Based on the Price/Forward Earnings ratio, SMLR is valued cheaply inside the industry as 98.44% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.41. SMLR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.82 | ||
| Fwd PE | 7.79 |
4.2 Price Multiples
SMLR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SMLR is cheaper than 97.92% of the companies in the same industry.
SMLR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SMLR is cheaper than 97.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.26 | ||
| EV/EBITDA | 5.8 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of SMLR may justify a higher PE ratio.
PEG (NY)0.38
PEG (5Y)0.31
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SMLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEMLER SCIENTIFIC INC
NASDAQ:SMLR (5/3/2024, 7:18:51 PM)
After market: 27 0 (0%)27
+0.48 (+1.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap189.81M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.82 | ||
| Fwd PE | 7.79 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.38
PEG (5Y)0.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.36% | ||
| ROE | 28.67% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 32.64% | ||
| PM (TTM) | 30.18% | ||
| GM | 89.76% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 10.64 | ||
| Quick Ratio | 10.56 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)53.63%
EPS 3Y16.48%
EPS 5Y
EPS growth Q2Q
EPS Next Y26.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.28%
Revenue growth 3Y20.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y